Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo (2020)
Attributed to:
Accelerating translational research through Cardiff University’s Clinical Innovation pipeline
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17125
PubMed Identifier: 32996123
Publication URI: http://europepmc.org/abstract/MED/32996123
Type: Journal Article/Review
Parent Publication: British Journal of Haematology
Issue: 1
ISSN: 0007-1048